+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Insomnia Drugs Market by Drug Class, Formulation, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889526
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The insomnia drugs market is rapidly evolving in response to changing patient needs, technological advancements, and shifting regulatory frameworks. As healthcare providers and stakeholders search for effective, well-tolerated therapeutic options, data-driven strategies and innovation are redefining how insomnia is managed worldwide.

Market Snapshot: Insomnia Drugs Market

The Insomnia Drugs Market grew from USD 3.07 billion in 2024 to USD 3.25 billion in 2025. It is expected to continue growing at a CAGR of 5.77%, reaching USD 4.30 billion by 2030.

Scope & Segmentation

  • Drug Classes: Antihistamines, benzodiazepines, melatonin receptor agonists, non-benzodiazepines (eszopiclone, zaleplon, zolpidem), orexin receptor antagonists (daridorexant, lemborexant, suvorexant)
  • Formulations: Capsules, injectables, oral suspensions, sublingual tablets, tablets
  • Routes of Administration: Intravenous, oral, sublingual, transdermal
  • Distribution Channels: Drug stores, hospital pharmacies (private, public), online pharmacies (B2C platforms, manufacturer sites, telepharmacy), retail pharmacies (chain, independent, supermarket)
  • End Users: Ambulatory care centers, clinics, home care, hospitals (private, public)
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, and others), Asia-Pacific (China, India, Japan, Australia, and others)
  • Companies Profiled: Sanofi S.A., Sunovion Pharmaceuticals Inc., Merck & Co., Inc., Eisai Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Avadel Pharmaceuticals plc, Idorsia Ltd., Viatris Inc.

Key Takeaways

  • Growing demand for innovative therapies is driving development of new drug classes that address efficacy and tolerability gaps in existing insomnia treatments.
  • Digital health technologies, including precision dosing and remote monitoring tools, are shaping treatment personalization and adherence strategies across patient segments.
  • Collaborative partnerships between pharmaceutical firms and digital health providers are supporting integrated care solutions and real-world data collection.
  • Regional market differences are pronounced, with the Americas showing maturity and high adoption of advanced therapeutics, while Asia-Pacific emerges as a high-growth opportunity driven by rising healthcare investments.
  • Formulation and administration trends underscore the market’s responsiveness to patient convenience and specific care settings, including rapid-onset and pediatric applications.

Tariff Impact: Navigating US Regulatory Shifts

The introduction of United States tariffs in 2025 has added complexity to global supply chains for insomnia drugs. Manufacturers are adapting procurement and manufacturing strategies to manage increased costs, accelerate local production, or utilize tariff exemptions. These changes affect not only cost structures, but also strategic planning for market entry, especially for new competitors. Established players with robust regional alliances have greater flexibility in navigating price pressures, while engagement with policymakers and trade bodies has become essential.

Methodology & Data Sources

This report integrates insights from secondary research including peer-reviewed publications and regulatory documentation, combined with primary interviews from over 50 industry and clinical stakeholders. Rigorous frameworks such as SWOT analysis and Porter’s Five Forces inform assessment of therapeutic classes, competition, and supply chains. All findings are validated against proprietary and regulatory data to uphold data integrity.

Why This Insomnia Drugs Market Report Matters

  • Offers actionable segmentation intelligence to support strategic product positioning and regional entry decisions.
  • Informs investment planning through detailed analysis of innovation, therapy evolution, and shifting regulatory requirements.
  • Equips stakeholders with robust market perspectives anchored in validated, real-world data and industry expert insights.

Conclusion

A dynamic landscape defined by innovation, regulatory shifts, and regional diversity characterizes the insomnia drugs market. Senior leaders equipped with this intelligence will be positioned to make informed investment choices and respond proactively to changing market conditions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Insomnia Drugs Market, by Drug Class
8.1. Introduction
8.2. Antihistamines
8.3. Benzodiazepines
8.4. Melatonin Receptor Agonists
8.5. Non-Benzodiazepines
8.5.1. Eszopiclone
8.5.2. Zaleplon
8.5.3. Zolpidem
8.6. Orexin Receptor Antagonists
8.6.1. Daridorexant
8.6.2. Lemborexant
8.6.3. Suvorexant
9. Insomnia Drugs Market, by Formulation
9.1. Introduction
9.2. Capsules
9.3. Injectables
9.4. Oral Suspensions
9.5. Sublingual Tablets
9.6. Tablets
10. Insomnia Drugs Market, by Route of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
10.4. Sublingual
10.5. Transdermal
11. Insomnia Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Drug Stores
11.3. Hospital Pharmacies
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Online Pharmacies
11.4.1. General B2C Platforms
11.4.2. Manufacturer Direct Sites
11.4.3. Telepharmacy Services
11.5. Retail Pharmacies
11.5.1. Chain Pharmacies
11.5.2. Independent Pharmacies
11.5.3. Supermarket Pharmacies
12. Insomnia Drugs Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Home Care
12.5. Hospitals
12.5.1. Private Hospitals
12.5.2. Public Hospitals
13. Americas Insomnia Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Insomnia Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Insomnia Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Sunovion Pharmaceuticals Inc.
16.3.3. Merck & Co., Inc.
16.3.4. Eisai Co., Ltd.
16.3.5. Takeda Pharmaceutical Company Limited
16.3.6. Johnson & Johnson
16.3.7. Teva Pharmaceutical Industries Ltd.
16.3.8. Avadel Pharmaceuticals plc
16.3.9. Idorsia Ltd.
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INSOMNIA DRUGS MARKET MULTI-CURRENCY
FIGURE 2. INSOMNIA DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. INSOMNIA DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INSOMNIA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MELATONIN RECEPTOR AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ESZOPICLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZALEPLON, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ZOLPIDEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DARIDOREXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY LEMBOREXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUVOREXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY GENERAL B2C PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY MANUFACTURER DIRECT SITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY SUPERMARKET PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. CANADA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 81. CANADA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 82. CANADA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. CANADA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 86. CANADA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. CANADA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. CANADA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 98. MEXICO INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 148. GERMANY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 149. GERMANY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. GERMANY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 159. FRANCE INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 160. FRANCE INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 161. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 164. FRANCE INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165. FRANCE INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. FRANCE INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. FRANCE INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. ITALY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. ITALY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 181. ITALY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 182. ITALY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. ITALY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. ITALY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. ITALY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 186. ITALY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 187. ITALY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 188. ITALY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 192. SPAIN INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 193. SPAIN INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 194. SPAIN INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. SPAIN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SPAIN INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. SPAIN INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. SPAIN INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. SPAIN INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 236. DENMARK INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 237. DENMARK INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 238. DENMARK INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. DENMARK INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. DENMARK INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. DENMARK INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. DENMARK INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 243. DENMARK INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. DENMARK INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 256. QATAR INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 257. QATAR INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 258. QATAR INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 259. QATAR INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. QATAR INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. QATAR INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 263. QATAR INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 264. QATAR INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. QATAR INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. QATAR INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 271. FINLAND INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. FINLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. FINLAND INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 274. FINLAND INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 275. FINLAND INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 276. FINLAND INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. FINLAND INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. EGYPT INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 301. EGYPT INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 302. EGYPT INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 303. EGYPT INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 304. EGYPT INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. EGYPT INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. EGYPT INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 307. EGYPT INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. EGYPT INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. EGYPT INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. EGYPT INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 313. TURKEY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 314. TURKEY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 315. TURKEY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 316. TURKEY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. TURKEY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 318. TURKEY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 319. TURKEY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 320. TURKEY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. TURKEY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 333. NORWAY INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 334. NORWAY INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 335. NORWAY INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 336. NORWAY INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 337. NORWAY INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 338. NORWAY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. NORWAY INSOMNIA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 340. NORWAY INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 341. NORWAY INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 342. NORWAY INSOMNIA DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. NORWAY INSOMNIA DRUGS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 344. POLAND INSOMNIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 345. POLAND INSOMNIA DRUGS MARKET SIZE, BY NON-BENZODIAZEPINES, 2018-2030 (USD MILLION)
TABLE 346. POLAND INSOMNIA DRUGS MARKET SIZE, BY OREXIN RECEPTOR ANTAGONISTS, 2018-2030 (USD MILLION)
TABLE 347. POLAND INSOMNIA DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 348. POLAND INSOMNIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 349. POLAND

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Insomnia Drugs market report include:
  • Sanofi S.A.
  • Sunovion Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Avadel Pharmaceuticals plc
  • Idorsia Ltd.
  • Viatris Inc.

Table Information